Company Facts & Figures

Teva is committed to developing and producing innovative and quality medicines for the patients we serve around the world. This is how we are helping people to live healthier lives.

01

Enabling access to quality medicines and treatment options

1,800
medicines
43,000
employees
200,000,000
people served every day

Teva offers the world’s largest medicine cabinet - a full spectrum of products from generics, API and over-the-counter products to specialty and biologic treatments.

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year 01. We have over 70 manufacturing facilities in more than 30 countries 01.

We rank among the leading pharmaceutical companies in the world and are active in 60 markets. Approximately 43,000 employees around the world are dedicated to our mission. Our innovative and high quality medicines serve about 200 million people every day 02.

View the full Teva Infographic
02

Focused specialty leadership centered on core therapeutic areas

Migraine and headache

Pain

Movement disorders and neurodegeneration

Respiratory

03

Global generic leadership

$
Billion
259
in savings to US healthcare system
in the past decade

Top 3 leadership position in over 25 markets

1 in 9
prescriptions in the US
1 in 8
prescriptions in Germany
1 in 6
prescriptions in the UK
04

Global Reach

60
Commercial presence in 60 Markets
3,500
Portfolio of different products globally
05

A fully integrated R&D function

25 R&D and clinical development sites.

270
Pending product registrations pending FDA approval
550
Over pending product approvals in International Markets
450
Generic launches globally in 2018
06

Strong operational base and global infrastructure and scale

70
production sites
120
billion tablets & capsules annually

Footnotes

  1. Back to contents.

    Data source for number of products & facilities: Teva Global Operations

  2. Back to contents.

    Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. Ref 2.1 dated August 2016; Ref 2.2 dated April 2019